• Repurposing Novobiocin: In Vitro Efficacy Against SFTSV

  2026-04-22

  This study systematically screened FDA-approved drugs for antiviral activity against severe fever with thrombocytopenia syndrome virus (SFTSV), identifying Novobiocin as a promising candidate with notable in vitro efficacy and minimal cytotoxicity. The findings highlight the potential of aminocoumarin antibiotics for antiviral repurposing, supporting further translational research.

• Partial BACE1 Inhibition Reduces Amyloid-β Without Synaptic

  2026-04-22

  Satir et al. (2020) demonstrate that partial inhibition of BACE1—reducing amyloid-beta secretion by up to 50%—does not impair synaptic transmission in cultured neurons. This finding suggests that moderate amyloidogenic pathway modulation may mitigate Alzheimer’s pathology while preserving neuronal function.

• Revisiting Sumatriptan Succinate Metabolism: CYP and MAO Pat

  2026-04-21

  This article analyzes recent evidence revising the metabolic fate of Sumatriptan Succinate, a selective 5-HT1 receptor agonist. The referenced study reveals that, contrary to prior assumptions, both monoamine oxidase A (MAO A) and specific cytochrome P450 (CYP) isoforms contribute to sumatriptan's biotransformation, with implications for migraine research and serotonergic pathway interrogation.

• Stiripentol as an LDH Inhibitor: Workflow Innovation for Epi

  2026-04-21

  Stiripentol, a novel LDH inhibitor from APExBIO, empowers both epilepsy and advanced immunometabolic research by enabling precise modulation of lactate dynamics. This guide demystifies the transition from bench protocol to translational insight—highlighting how Stiripentol streamlines metabolic assays, supports astrocyte-neuron lactate shuttle studies, and overcomes common experimental pitfalls.

• Sequencing Therapies in Waldenström Macroglobulinemia: Evide

  2026-04-20

  This article analyzes recent advances in the sequencing of therapies for Waldenström Macroglobulinemia (WM), focusing on the integration of genomic profiling to guide clinical decisions. The reviewed paper provides a detailed synthesis of current treatment regimens, mutation-driven stratification, and the rationale for emerging therapeutic strategies, highlighting key considerations for translational researchers and clinicians.

• Meropenem in In Vivo Infection Models: Mechanistic Insights

  2026-04-20

  Explore how Meropenem, a leading β-lactam antibiotic carbapenem, enables advanced research in in vivo Gram-negative and Gram-positive infection models. This article uniquely dissects mechanistic action, nanoparticle delivery, and practical assay design for translational breakthroughs.

• Mechanistic Insights into Diuron-Induced Acute Kidney Injury

  2026-04-19

  This study integrates network toxicology, transcriptomic analysis, and experimental validation to uncover how Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) induces acute renal injury via the JAK2/STAT1 pathway. The findings provide a mechanistic foundation for understanding Diuron toxicity and informing future risk assessments in environmental toxicology.

• HyperFluor™ 594 Goat Anti-Rabbit IgG: Quantitative Precision

  2026-04-18

  Explore how the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody elevates quantitative accuracy and assay reliability in immunocytochemistry, immunohistochemistry, and flow cytometry. This article uniquely dissects protocol optimization and translational decision-making in light of recent causal immunogenomics research.

• Fludarabine as a Genomic Profiling Tool in Hematologic Oncol

  2026-04-17

  Explore the unique role of Fludarabine as a DNA synthesis inhibitor in precision leukemia research. This article delves into its mechanistic action, integration with genomic profiling, and advanced applications, offering insights not covered in current literature.

• ARCA Cy3 EGFP mRNA (5-moUTP): Mechanistic Insights and Preci

  2026-04-16

  Explore the molecular mechanisms and assay optimization potential of ARCA Cy3 EGFP mRNA (5-moUTP), a 5-methoxyuridine modified mRNA. This article uniquely bridges structural innovation and workflow decisions for advanced mRNA transfection studies.

• GRA12 Identified as Key Virulence Factor Across Toxoplasma S

  2026-04-15

  This study employed in vivo CRISPR screening to pinpoint GRA12 as a conserved secreted virulence factor critical for Toxoplasma gondii infection across diverse parasite strains and mouse subspecies. The findings illuminate a shared immune evasion mechanism relevant to host-pathogen interaction studies and translational research targeting apoptosis pathways.

• Methoxy-X04: Precision Fluorescent Amyloid Beta Probe for Tr

  2026-04-14

  Explore how Methoxy-X04, a next-generation fluorescent amyloid beta probe, is transforming translational Alzheimer's disease research. This article uniquely bridges high-resolution imaging with the latest neuroimmune modulation insights for practical, advanced assay design.

• Tacrine Hydrochloride Hydrate: Optimizing Neurodegenerative

  2026-04-13

  Tacrine hydrochloride hydrate (Tetrahydroaminacrine) is a benchmark acetylcholinesterase inhibitor powering reproducible Alzheimer's disease research. This guide translates the latest evidence into actionable workflows, troubleshooting strategies, and advanced applications for maximizing assay sensitivity and reproducibility.

• rTMS Enhances Amyloid Clearance via Cx3cl1-Cx3cr1 in Alzheim

  2026-04-13

  This study demonstrates that repetitive transcranial magnetic stimulation (rTMS) promotes cognitive recovery in Alzheimer’s disease by activating GABAergic neurons and enhancing microglial amyloid clearance through the Cx3cl1-Cx3cr1 axis. These findings advance mechanistic understanding of non-invasive interventions and suggest novel molecular targets for translational Alzheimer’s disease research.

• Applied Workflows with EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Dual

  2026-04-12

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) empowers advanced mRNA delivery studies by enabling simultaneous tracking of mRNA uptake and translation efficiency. Its dual Cy5 and EGFP labeling, Cap 1 structure, and immune-evasive modifications provide unmatched clarity in quantitative transfection and gene regulation assays.

16026 records 1/1069 page Next 12345 下5页 Last page